Abeer Altaf

Dr. Abeer Altaf

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2021 in Cureus
Verified
Journal Article
Open access
AAAbeer Altaf
Abeer Altaf
ZAZaigham Abbas
Zaigham Abbas
HMHaider A Mandviwalla
Haider A Mandviwalla
MQMuhammad Ali Qadeer
Muhammad Ali Qadeer
MSMehreen Siyal
Mehreen Siyal
MAMahnoor Ali
Mahnoor Ali
Objective: Coronavirus disease 2019 (COVID-19) is known to disturb liver function tests (LFTs). Not much literature is available regarding the effect of COVID-19 on LFTs in patients without preexisting liver disease. The study aimed to find the effect of COVID-19 in these patients. Methods: This was a single-center, observational study with 142 patients who were admitted with COVID-19 during three months. Seven patients were excluded due to the presence of chronic liver disease. Results: A total of 135 patients were included in the study aged between 18 and 95 years (mean 57.7 ± 15.6); among them, 93 were males (68.9%). Hypertension was present in 74 patients (54.8%), and diabetes was present in 48 patients (35.6%). Fever was the chief complaint in 112 patients (83%), followed by dyspnea in 93 patients (68.9%) and cough in 79 patients (58.5%). Elevated aspartate aminotransferase (AST) was seen in 35 patients (26%), gamma-glutamyl transferase (GGT) in 43 patients (32%), alanine transaminase (ALT) in 18 patients (24%), alkaline phosphatase in 19 patients (14%), bilirubin in six patients (4%), and low albumin in 27 patients (20%). Severe COVID-19, when compared with mild to moderate disease, was associated with elevated AST > two-time upper limit normal (2ULN) (p = 0.002), GGT > 2ULN (0.026), and lower albumin (p = 0.020), higher systemic inflammatory response syndrome (SIRS) (0.045), raised procalcitonin (p = 0.045), higher ferritin (p = 0.005), lower pO2 (p = 0.044), and higher Sequential Organ Failure Assessment score (SOFA) (p = 0.002) pointing to the inflammatory response as cause of liver injury. Factors predicting mortality with COVID-19 were assessed, which showed that direct bilirubin (p = 0.001), low albumin (p = 0.013), tachypnea (0.002), and leukocytosis (<0.001) were independently associated with increased COVID-19-related mortality. Conclusion: Patients suffering from COVID-19 have evidence of liver injury, which appears to be secondary to an inflammatory response that correlates with the severity of COVID-19.

27 July 2025 in Cureus
Verified
Journal Article
Open access
PDF file
AAAbeer Altaf
Abeer Altaf
ZAZaigham Abbas
Zaigham Abbas
MQMuhammad Ali Qadeer
Muhammad Ali Qadeer
MSMehreen Siyal
Mehreen Siyal
Objective Metabolic dysfunction-associated steatotic liver disease (MASLD) can rapidly progress to steatohepatitis, liver fibrosis, and hepatocellular carcinoma. However, it is a multisystem disease, and most of the MASLD-related morbidity and mortality is due to its extrahepatic complications. In light of the growing impact of MASLD on extrahepatic organs, we aimed to evaluate spleen fat deposition and compare it with liver fat deposition by vibration-controlled transient elastography using its attenuation parameter. Design Eighty patients from the outpatient department, who met the criteria of MASLD, were included in the study. Both liver and spleen elastography were performed via FibroScan at the same time before treatment. Results Out of the 80 people studied, 69 (86.3%) were male patients. Their age ranged from 22 to 86 years (mean 42.44± 11.92), and BMI ranged between 20.5 to 39.8 kg/m2 (28.12± 3.99). Hypertension was present in 45 (56.3%) patients. Sixteen (20%) patients had mild liver steatosis, 26 (32.5%) had moderate, and 28 (35%) patients recorded the presence of severe fatty liver. Using the same cut-off values for spleen, 28 (35%) patients had normal attenuation (steatosis), four (5%) had mild spleen steatosis, 17 (21.3%) had moderate, and 31 (38.8%) patients had severe fatty spleen. A bivariate correlation analysis revealed a significant correlation between hepatic and splenic steatosis (p=0.01). Furthermore, patients with elevated spleen steatosis demonstrated higher liver fat content as indicated by raised liver controlled attenuation parameter (CAP) values (289.79±30.10 dB/m) compared to those without spleen steatosis (264.67±41.85 dB/m). Conclusion This study shows correlation of fatty liver with that of steatosis of the spleen, highlighting the extrahepatic multiorgan effects of the MASLD.

25 April 2026 in Journal of Medical Case Reports
Verified
Journal Article
Open access
AAAbeer Altaf
Abeer Altaf
SNSaad Khalid Niaz
Saad Khalid Niaz
SKShanil Kadir
Shanil Kadir
Hepatic fascioliasis is a zoonotic infection caused by Fasciola hepatica. It is underdiagnosed due to its non-specific clinical presentation and limited diagnostic tools in many healthcare settings. Human infections, though uncommon, are rising in endemic areas. We report a 40-year-old South Asian female presenting with a 3-month history of vague right hypochondrial pain, nausea, and poor appetite. Laboratory tests showed cholestatic jaundice. Abdominal ultrasound revealed gallbladder sludge and a dilated common bile duct. ERCP was performed and revealed live Fasciola hepatica worms in the biliary tree. Post-extraction, she was treated with albendazole with complete resolution of symptoms and normalization of liver biochemistry. This case highlights the importance of considering hepatic fascioliasis in patients with atypical hepatobiliary symptoms, especially in endemic regions. ERCP played a pivotal role in both diagnosis and management.

12 June 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
AJAnum Jamil
Anum Jamil
WNWaseemullah Nazir
Waseemullah Nazir
AAAbeer Altaf
Abeer Altaf
SNSaad Khalid Niaz
Saad Khalid Niaz
Background/Objectives: Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP) is a clinically significant complication of ERCP, occurring in approximately 2–10% of general cases and at higher rates in high-risk patients. Early prediction of PEP risk may support timely intervention and improved patient management. This retrospective single-center study comparatively evaluated tabular clinical data, endoscopic image data, and multimodal fusion approaches for PEP prediction. Methods: Retrospective data collected from the Sindh Institute of Advanced Endoscopy and Gastroenterology were analyzed using machine learning and deep learning techniques. XGBoost(version 3.2.0) was applied to tabular clinical data, while EfficientNet-B0, ResNet50, and DenseNet201 were used for endoscopic image analysis. A multimodal contrastive learning (MMCL)-based framework combining ResNet50 image features with multilayer perceptron (MLP)-based tabular features was additionally implemented for binary PEP prediction. Class imbalance mitigation techniques, including data augmentation and balancing strategies, were applied during training. Model performance was evaluated using the area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, F1-score, and precision. SHAP analysis was performed to identify important predictive features. Results: The tabular XGBoost model achieved the best predictive performance with an AUC of 0.95 and a sensitivity of 0.50, while five-fold cross-validation yielded an AUC of 0.79 and a sensitivity of 0.48. Among image-based models, ResNet50 achieved the highest performance, with an AUC of 0.76 and a sensitivity of 0.40. The multimodal model achieved an AUC of 0.57 and a sensitivity of 0.20. SHAP analysis identified cannulation time, ampulla type, and age as prominent features associated with PEP prediction. Conclusions: This exploratory study suggests that structured clinical data currently provide stronger predictive signals for PEP prediction than the available image and multimodal data within this limited cohort. The relatively low occurrence of PEP contributed to class imbalance despite mitigation strategies. Future multicenter studies with larger datasets, improved image availability, synthetic data generation, and advanced multimodal fusion techniques may improve predictive performance and clinical applicability.

1 May 2021 in Asian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
MQMuhammad Ali Qadeer
Muhammad Ali Qadeer
ZAZaigham Abbas
Zaigham Abbas
MAMuhammad Asim
Muhammad Asim
SAShoukat Ali
Shoukat Ali
AAAbeer Altaf
Abeer Altaf
Background: Regular educational activities have suffered since the start of COVID-19 pandemic. New data has been emerging regularly regarding COVID-19 and the optimal way of care for patients with COVID-19 infection. Emphasis upon dispensing knowledge in current pandemic times should be made. Aims and Objective: We assessed the knowledge of internal medicine and gastroenterology trainees regarding liver involvement and related issues in the current COVID-19 pandemic. Materials and Methods: This online survey comprised of 10 questions designed to examine the basic knowledge of Sars-Cov-2 virus, knowledge regarding liver involvement in COVID-19, and the ability to decide on patient care. Results: A total of 100 responses were collected. Most of the responses were from Pakistan (n=75). More than 80% of trainees responded correctly regarding the accurate indication of endoscopic procedures during COVID-19 pandemic, absence of ACE-II receptor expression on astrocytes, upper respiratory secretions being an eligible sample for SARSCOV- II, avoiding regular outpatient follow up, avoiding hydroxychloroquine as a prophylactic drug, and azithromycin in decompensated cirrhosis, continuing beta-blockers and lactulose in a decompensated patient, melena being an accurate indication for screening endoscopy and the choosing right set of PPEs. Less than 50% of responders knew correctly regarding NAFLD being a notorious factor for COVID-19 related complications, ACE-II receptor expression by cholangiocytes and enterocytes, saliva and stool being an eligible sample for SARS-COV-II detection, palliative approach as an appropriated management step for decompensated-CLD patients and history of ascites as an appropriate indication for screening endoscopy. GItrainees performed better in some areas of knowledge. Conclusions: Trainees were updated in many aspects of the recent guidance in the management of COVID-19 but there were many lacunae in the knowledge. So, continuous medical education activities are essential to keep the residents updated about the changing developments in the management of COVID-19.

13 January 2026 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
AAAbeer Altaf
Abeer Altaf
JSJaveria Salman
Javeria Salman
MAMuhammad Asim
Muhammad Asim
MTMuhammad Umair Tahseen
Muhammad Umair Tahseen
BABushra Ayub
Bushra Ayub
SNSaad Niaz
Saad Niaz
Pancreatic pseudocyst is a frequent complication of pancreatitis. Endoscopic ultrasound (EUS) being the standard approach for drainage, along with conventional transgastric (CTG) remains an alternative, but comparative real-world data from resource-limited settings remain scarce. A retrospective review was conducted at a tertiary-care center in Pakistan from 2015 to 2025. Patients undergoing pseudocyst drainage via CTG or EUS were compared for demographic variables, technical success, complications, and procedure costs. Logistic regression was used to identify predictors of either modality for drainage. A total of 164 patients underwent pseudocyst drainage, including 96 (58.5%) treated with EUS-guided drainage and 68 (41.5%) with CTG. Mean age was 32.76 ± 16.65 years (range 4–77), with 42 pediatric patients. Abdominal pain was the most common presenting symptom. Pseudocysts treated with CTG were significantly larger than those treated with EUS (15.02 ± 8.20 mm vs. 8.49 ± 2.53 mm; P < 0.001). Technical success rates were comparable between groups (EUS 96.9% vs. CTG 98.5%; P = 0.499), with no significant difference in complications or 6-month clinical outcomes. EUS-guided procedures incurred higher instrument costs (PKR 330,500 vs. PKR 197,500). Larger cyst size was independently associated with CTG selection, whereas EUS was more commonly used in hospitalized patients. EUS-guided and conventional transgastric drainage demonstrate comparable safety and efficacy. In resource-limited settings, CTG remains a cost-effective option in appropriately selected patients.